Chronic limb-threatening ischemia
Conditions
Interventions
None listed
Sponsors
Boston Scientific Japan K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients intended to be treated with Peripheral RotablatorPRO
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of adverse events related to the use of the device and angiographic events, including vascular dissection, vessel perforation, and distal embolization, will be evaluated. In addition, the incidence of device malfunction events, including guidewire fracture, retained guidewire, difficulty in guidewire removal, and difficulty in burr removal, will be evaluated. | — |
Countries
Japan
Contacts
Public ContactHiroshi Sakamoto
Boston Scientific Japan K.K. Clinical Affairs
Outcome results
None listed